Meadowhawk Biolabs, Inc.
Mary Ann Gallo is an experienced professional in the pharmaceutical and biotechnology industries, currently serving as Vice President of Sales & Marketing at Meadowhawk Biolabs, Inc. since September 2021, overseeing operations in Boston and San Francisco. Prior to this role, Gallo held senior leadership positions, including Senior Director of Business Development at KCAS Bioanalytical & Biomarker Services and Director of Business Development at Agilux Laboratories. Additional experience includes positions as Director of Business Development for Preclinical Services at Ricerca Biosciences, Senior Director of Business Development at Bridge Global Pharmaceutical Services, and Senior Account Manager at Charles River Laboratories. Gallo began an academic career as a Research Associate at Centocor. Educational qualifications include an M.S. in Human Anatomy from Drexel University College of Medicine and a BA in Biology from Quinnipiac University.
Meadowhawk Biolabs, Inc.
Meadowhawk biolabs is a CRO that was created to make a difference for our pharmaceutical and biotech clients in drug discovery and development. Our curiosity, unwillingness to accept the status quo and unflagging commitment and alignment to our values drives us to partner with our clients to bring new treatments and therapeutics faster to patients.